Fusion Pharmaceuticals US Inc
Associate Director/Director of Radiation Biology and Late Development Fusion Pharmaceuticals, a member of the AstraZeneca Group, is a clinical stage oncology company focused on developing next generation radioconjugates (RCs) as precision medicines. Fusion connects alpha particle emitting isotopes to various…
Associate Director/Director of Radiation Biology and Late Development Fusion Pharmaceuticals, a member of the AstraZeneca Group, is a clinical stage oncology company focused on developing next generation radioconjugates (RCs) as precision medicines. Fusion connects alpha particle emitting isotopes to various…
Associate Director/Director of Radiation Biology and Late Development Fusion Pharmaceuticals, a member of the AstraZeneca Group, is a clinical stage oncology company focused on developing next generation radioconjugates (RCs) as precision medicines. Fusion connects alpha particle emitting isotopes to various…
Fusion Pharmaceuticals, a member of the AstraZeneca Group, is a clinical stage oncology company focused on developing next generation radioconjugates (RCs) as precision medicines. Fusion connects alpha particle emitting isotopes to various targeting molecules to selectively deliver the alpha emitting…
Fusion Pharmaceuticals, a member of the AstraZeneca Group, is a clinical stage oncology company focused on developing next generation radioconjugates (RCs) as precision medicines. Fusion connects alpha particle emitting isotopes to various targeting molecules to selectively deliver the alpha emitting…
Fusion Pharmaceuticals, a member of the AstraZeneca Group, is a clinical stage oncology company focused on developing next generation radioconjugates (RCs) as precision medicines. Fusion connects alpha particle emitting isotopes to various targeting molecules to selectively deliver the alpha emitting…
Fusion Pharmaceuticals, a member of the AstraZeneca Group, is a clinical stage oncology company focused on developing next generation radioconjugates (RCs) as precision medicines. Fusion connects alpha particle emitting isotopes to various targeting molecules to selectively deliver the alpha emitting…
Fusion Pharmaceuticals, a member of the AstraZeneca Group, is a clinical stage oncology company focused on developing next generation radioconjugates (RCs) as precision medicines. Fusion connects alpha particle emitting isotopes to various targeting molecules to selectively deliver the alpha emitting…
Fusion Pharmaceuticals, a member of the AstraZeneca Group, is a clinical stage oncology company focused on developing next generation radioconjugates (RCs) as precision medicines. Fusion connects alpha particle emitting isotopes to various targeting molecules to selectively deliver the alpha emitting…